West Pharmaceutical Shares Jump After Strong Q2 Results and Higher 2026 Profit Guidance
West Pharmaceutical Services Inc. shares climbed sharply in pre-market trading after the company reported second-quarter 2026 results that exceeded analyst expectations on both earnings and revenue, raised full-year adjusted EPS guidance, and provided third-quarter guidance above Wall Street models. The rally was company-specific as major U.S. inde…